TY - JOUR
T1 - Medications and fall risk
T2 - a case–control study in nursing home residents in Japan
AU - Park, Hyerim
AU - Satoh, Hiroki
AU - Miki, Akiko
AU - Maki, Hideyuki
AU - Asai, Kohei
AU - Shiraishi, Akira
AU - Urushihara, Hisashi
AU - Sawada, Yasufumi
N1 - Funding Information:
The authors would like to thank the participants of this study; Yukari Konishi (Sompo Care Inc. employees) for data collection of care and medication of study participants; pharmacies operated by Wakaba, PFERCOS, CFS Corporation, and Miyonodai Yakkyoku Group for collecting pharmacy dispensing records of study participants.
Funding Information:
HS, AM, and YS received joint research funding from Sompo Care Inc., Nichi-Iko Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd. and belong to endowed department partially sponsored by Sompo Care Inc. and Nichi-Iko Pharmaceutical Co., Ltd. HM and KA are Sompo Care Inc. employees. AS is Wakaba Inc. employee. HU is a paid consultant of Eisai Co., Ltd. and Nippon Boehringer Ingelheim Co., Ltd. HP declares that there is no conflict of interest.
Publisher Copyright:
© 2019, Springer Nature Switzerland AG.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Aim: Falls are a significant problem for older people, but are few studies of the risk of falling in residents of nursing homes in Japan. We aimed to investigate the risk factors for falls and the association of medication use and falls in nursing home residents in Japan. Methods: This case–control study reviewed the records of residents of who were ≥ 65 years of age and had fallen in 2012 and an age-, sex-, and facility-matched control group selected from 58 nursing homes in Japan. The odds ratios of potential risk factors and current medications were determined by conditional logistic regression. Results: A total of 1832 residents (916 cases and 916 controls) were included. Falls were significantly associated with an inability to walk without assistance or stand up without assistance, need for toileting assistance, visual impairment, insomnia, and dementia. Current prescription of antithrombotic, nonsteroidal anti-inflammatory, or antiparkinson drugs, muscle relaxants, antiepileptics, antipsychotics, antidepressants, opioids, selective serotonin reuptake inhibitors, and memantine was also associated with increased risk of falling. Conclusions: Many medications were associated with falls in nursing homes residents in Japan. To prevent these falls, caregivers should provide adequate care, and healthcare professionals should consider switching or dose reduction for these medications.
AB - Aim: Falls are a significant problem for older people, but are few studies of the risk of falling in residents of nursing homes in Japan. We aimed to investigate the risk factors for falls and the association of medication use and falls in nursing home residents in Japan. Methods: This case–control study reviewed the records of residents of who were ≥ 65 years of age and had fallen in 2012 and an age-, sex-, and facility-matched control group selected from 58 nursing homes in Japan. The odds ratios of potential risk factors and current medications were determined by conditional logistic regression. Results: A total of 1832 residents (916 cases and 916 controls) were included. Falls were significantly associated with an inability to walk without assistance or stand up without assistance, need for toileting assistance, visual impairment, insomnia, and dementia. Current prescription of antithrombotic, nonsteroidal anti-inflammatory, or antiparkinson drugs, muscle relaxants, antiepileptics, antipsychotics, antidepressants, opioids, selective serotonin reuptake inhibitors, and memantine was also associated with increased risk of falling. Conclusions: Many medications were associated with falls in nursing homes residents in Japan. To prevent these falls, caregivers should provide adequate care, and healthcare professionals should consider switching or dose reduction for these medications.
KW - Accidental falls
KW - Comorbidity
KW - Nursing home
KW - Prescription drugs
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85069481163&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069481163&partnerID=8YFLogxK
U2 - 10.1007/s40520-019-01265-9
DO - 10.1007/s40520-019-01265-9
M3 - Article
C2 - 31317520
AN - SCOPUS:85069481163
SN - 1594-0667
VL - 32
SP - 885
EP - 892
JO - Aging Clinical and Experimental Research
JF - Aging Clinical and Experimental Research
IS - 5
ER -